SBWire

The other dairy products category continued developing in 2012 mainly thanks to consumers' interest in these products for their healthy features. Dairy products are always very highly valued in Uzbekistan, whereas rotation of different varieties is considered helpful for internal organs and the digestive system. Moreover, doctors often recommend consumption of products, such as fromage frais and quark for children, adults and especially expectant mothers.

The 2% volume growth and 6% value growth recorded in dried processed food in Bosnia-Herzegovina during 2012 were commensurate with the 2% volume CAGR and 6% current value CAGR recorded over the entire review period. This suggests that the performance of dried processed food in Bosnia-Herzegovina during 2012 was very much in line with previously established growth rates as the main trends remained stable. The main reason for the rising demand dried processed food during 2012 was the high levels...

Surface care in Canada is about perception as much as it is about the actual cleaning regimen in the home. With various health scares in recent memory, from SARS and swine flu to food contamination, most Canadians are concerned about the cleanliness of the surfaces in their home. Canadians continue to seek faster and easier ways to prevent bacteria spreading within their personal surroundings, while at the same time opting for products that offer convenience and ease of use, such as general...

Synopsis Canadean's, "Still Drinks Market in East Europe to 2017: Market Guide" provides in-depth detail on the trends and drivers of the Still Drinks market in East Europe. The quantitative data in the report (historic and forecast consumption values) analyses the dynamics in the East European countries, providing marketers with the essential information to understand their own and their competitors' position in this market and the information to accurately identify where to compete in the future.

Espicom’s in-depth medical device market reports are ideal for executives wanting to understand the key drivers in medical markets and have access to a wealth of statistical data. Each report opens with an outlook section that provides analysis of the market, 5-year market forecasts, national data projections, market outlook and key developments such as regulation, health facilities and government policy. The report also provides extensive background information, population trends, health status, health expenditure, organisation & administration, hospital services, medical personnel, healthcare development, market access information, trade data and essential industry contacts. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year. Finland is one of the northernmost countries in Europe and covers around 338,000km2, of which 10% is water. The population is estimated at 5.4 million in 2012.

GlobalData has released its new PharmaPoint Drug Evaluation report, "Trobalt/Potiga (Epilepsy) - Forecast and Market Analysis to 2022". Epilepsy is a brain disorder characterized by spontaneously occurring and recurrent seizures. The market is heavily driven by the sales of antiepileptic drugs (AEDs) targeted at seizure reduction. The AED market is currently dominated by UCB's Keppra and GlaxoSmithKline's Lamictal. Although both drugs have experienced significant generic erosion, they form the mainstay of epilepsy treatment in the nine markets and will continue to have significant market share during the forecast period. Other key drugs include older generation AEDs such as Pfizer's Dilantin, Abbott's Depakote, and Novartis' Tegretol and Trileptal which still have significant usage due to their longevity in the market. However, the AED dominance landscape will continue to shift towards newer generation drugs particularly following the recent market entry of GlaxoSmithKline's Trobalt/Potiga and Eisai's Fycompa which both offer first-in-class mechanisms of action.

GlobalData has released its new PharmaPoint Drug Evaluation report, "Lamictal (Epilepsy) - Forecast and Market Analysis to 2022". Epilepsy is a brain disorder characterized by spontaneously occurring and recurrent seizures. The market is heavily driven by the sales of antiepileptic drugs (AEDs) targeted at seizure reduction. The AED market is currently dominated by UCB's Keppra and GlaxoSmithKline's Lamictal. Although both drugs have experienced significant generic erosion, they form the mainstay of epilepsy treatment in the nine markets and will continue to have significant market share during the forecast period. Other key drugs include older generation AEDs such as Pfizer's Dilantin, Abbott's Depakote, and Novartis' Tegretol and Trileptal which still have significant usage due to their longevity in the market. However, the AED dominance landscape will continue to shift towards newer generation drugs particularly following the recent market entry of GlaxoSmithKline's Trobalt/Potiga and Eisai's Fycompa which both offer first-in-class mechanisms of action.

GlobalData's clinical trial report, "Aortic Aneurysm Global Clinical Trials Review, H1, 2013" provides data on the Aortic Aneurysm clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Aortic Aneurysm. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Aortic Aneurysm. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

GlobalData's new report, "Saudi Arabia Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others" provides key market data on the Saudi Arabia Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within market categories - Infusion Systems, Metered Dose Inhaler Devices, Central Venous Catheters and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

GlobalData's new report, "Cepheid Market Share Analysis" provides in-depth information on Cepheid's market position in the different medical equipment markets it operates in. The report provides Cepheid market share information in two key market categories - Genetic Testing and Infectious Immunology. The report also provides data and information on the overall competitive landscape of the markets, the company operates in. The report is supplemented with global corporate-level profile with information on the company's business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments.

GlobalData's clinical trial report, "Ventricular Fibrillation Global Clinical Trials Review, H1, 2013" provides data on the Ventricular Fibrillation clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ventricular Fibrillation. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Ventricular Fibrillation. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

GlobalData has released its new PharmaPoint Drug Evaluation report, "Xgeva (Prostate Cancer) - Forecast and Market Analysis to 2022". The recent approvals of second-line metastatic castration-resistant prostate cancer (mCRPC) therapies like J&J's Zytiga (abiraterone acetate) and Medivation/Astellas' Xtandi (enzalutamide) will drive strong market growth over the next decade. These safe and orally administered treatments will provide safety and convenience benefits over the current standard of care, chemotherapy with docetaxel, while prolonging the overall survival of patients with mCRPC. The December 12, 2012 FDA approval of Zytiga for the added indication of chemotherapy-naive mCRPC marks the onset of a new treatment paradigm for the disease, in which chemotherapy is relegated to second-line therapy and beyond. For patients with earlier-stage prostate cancer, androgen deprivation therapy with LHRH agonists and first-generation antiandrogens remains the standard of care for suppressing testosterone levels and temporarily controlling the disease.

Det Norske Veritas A/S (DNV), a provider of risk management services, and Germanischer Lloyd SE (GL), a provider of classification, verification and engineering consulting services, agreed to merge in order to further expand their service offerings in the maritime, oil and gas, energy, and business assurance sectors. The new combined company will be called DNV GL Group. The newly formed entity, through their common set of values and complementary strengths, is positioned to achieve a combined turnover of around EUR2.5 billion ($3.31 billion), with more than 17,000 employees and an extensive global network of offices to meet international competition and provide improved services to their customers.

GlobalData's report, Polyethylene Industry Outlook in France to 2016 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants provides an in-depth coverage of France Polyethylene industry. The research presents major market trends affecting the Polyethylene industry in France. The report covers France Polyethylene plants and presents installed capacity by key feedstock, process and technology. In addition, it presents Polyethylene demand and production forecasts, end use demand forecasts, price trends, trade balance data and company shares of the major Polyethylene producers in France. Overall, the report presents a comprehensive coverage of France Polyethylene industry including all the major parameters.

The report presents detailed data on consumption trends in the Male Fragrances category in Finland, analyzing consumption volumes and values at segment level. It also provides indispensable data on distribution channels.

The report presents detailed data on consumption trends in the Facial Care category in Bulgaria, analyzing consumption volumes and values. It also provides indispensable data on distribution channels, profiles of companies active in the Skincare sector andlatest industry news.

The report presents detailed data on consumption trends in the Internal Cleansers and Sprays category in Italy, analyzing consumption volumes and values. It also provides indispensable data on distribution channels, profiles of companies active in the Feminine Hygiene sector and mergers and acquisitions in the sector.

The report presents detailed data on consumption trends in the Solid Fats category in Italy, analyzing consumption volumes and values at segment level. It also provides indispensable data on distribution channels.

The report presents detailed data on consumption trends in the Syrups category in Italy, analyzing consumption volumes and values. It also provides indispensable data on distribution channels and mergers and acquisitions in the sector.

The report presents detailed data on consumption trends in the Toothpaste category in Brazil, analyzing consumption volumes and values at segment level. It also provides indispensable data on distribution channels, profiles of companies active in the Oral Hygiene sector andlatest industry news.

The report presents detailed data on consumption trends in the Take Home Ice Cream category in Brazil, analyzing consumption volumes and values at segment level. It also provides indispensable data on distribution channels, profiles of companies active in the Ice Cream sector.

The report presents detailed data on consumption trends in the Prepared Salads category in China, analyzing consumption volumes and values at segment level. It also provides indispensable data on distribution channels, latest industry news and mergers and acquisitions in the sector.

The report presents detailed data on consumption trends in the Post-Shave Cosmetics - Men's category in France, analyzing consumption volumes and values. It also provides indispensable data on distribution channels andlatest industry news.

The report presents detailed data on consumption trends in the Gum category in Italy, analyzing consumption volumes and values at segment level. It also provides indispensable data on distribution channels, profiles of companies active in the Confectionery sector, latest industry news and mergers and acquisitions in the sector.

The report presents detailed data on consumption trends in the Chilled Noodles category in Brazil, analyzing consumption volumes and values. It also provides indispensable data on distribution channels, profiles of companies active in the Pasta and Noodles sector and mergers and acquisitions in the sector.